Degludec
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 944 publications
Design and Evaluation of a Novel Clinical Decision Support Algorithm for Weekly Insulin Efsitora Alfa.
Journal: Journal of diabetes science and technology
Published: June 08, 2026
Evaluating once-weekly insulin efsitora alfa for adults with type 2 diabetes.
Journal: Expert opinion on pharmacotherapy
Published: April 28, 2026
A paradigm shift in diabetes care: clinical implications of once-weekly insulin icodec.
Journal: Annals of medicine and surgery (2012)
Published: April 12, 2026
Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus.
Journal: Biosensors
Published: March 18, 2026
Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli-D Study.
Journal: Diabetes, obesity & metabolism
Published: March 15, 2026
Comparative thromboembolic risk and polypharmacy-related drug-drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study.
Journal: Frontiers in pharmacology
Published: March 09, 2026
Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled Trial.
Journal: Diabetes technology & therapeutics
Published: February 06, 2026
Transition from CSII to second-generation basal insulin analogues in hospitalized T2DM patients: a CGM-based study.
Journal: BMC endocrine disorders
Published: January 27, 2026
Comparison chart: Some available insulins for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: January 23, 2026
Last Updated: 06/30/2026